Protox receives funding from NRC to develop lung cancer drug

 

Protox receives funding from NRC to develop lung cancer drug
Canada NewsWire (press release) - Canada
... The NRC has committed this money to the Company to support its development of Lung-H1, a therapeutic toxin for the treatment of non small cell lung cancer. ...

Genentech/Roche's Avastin Will Account for More Than 50% of the ...
PR Newswire (press release) - USA
Generics Erosion Threatens Three Major Drugs in the Lung Cancer Market, According to a New Study from Decision Resources Waltham, Mass., June 7 /PRNewswire ...

Agency unveils five-year plan to fight the increasing occurrence ...
eTaiwan News - Taipei,Taiwan
... Among the similarities to western trends, Huang said, was that lung cancer had replaced liver cancer as the most frequent cause of death from cancer in Taiwan. ...  

Research and Markets: More People Die of Lung Cancer Than of Colon ...
Yahoo News (press release) - USA
... Ireland, June 9 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/reports/c18898 ) has announced the addition of Lung Cancer Outlook to ...

Bethesda Lecture Tackles Lung Cancer, Progression
Bethesda Journal - Bethesda,MD,USA
The National Naval Medical Center and the National Cancer Institute hosted a lecture Friday in Laurel Clark Auditorium to discuss lung cancer and the strides ...

Mouse model paves way for lung cancer studies
News from Washington University in St. Louis (press release) - Saint Louis,Washington,USA
... free of lung tumors, even when exposed to heavy tobacco smoke, so there has been a shortage of models suitable for studying tobacco smoke-induced lung cancer. ...

Lung cancer? But I've never smoked
KING5.com (subscription) - Seattle,WA,USA
... But Tom believes in magic, especially after a nagging backache that turned into a surprising diagnosis: stage four lung cancer. "Parents never smoked. ...

Cancer skyrockets in women
Bakersfield Californian (subscription) - Bakersfield,CA,USA
... century. Now many of those women are faced with another decision: what type of lung cancer treatment will they choose. Michelle ...